Search

everythinglearnresearchcommunity

for

Search:↓

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The document does not determine if adults with aphallia are fertile.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

A young Russian girl with Meier-Gorlin syndrome has two new mutations in the CDC6 gene.

PCOS patients, especially obese ones, often lack vitamin D and may need supplements and lifestyle changes.

Some women with PCOS have rare genetic variants linked to the condition.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Sex hormones, especially androgens, play a key role in causing acne.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Oral contraceptives may cause hair loss in women.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.